RxDoctor Payments Data

John McCarthy, MD

Hand Surgery · Omaha, NENPI 1740221969

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 60.7% of it on its own, with 2 other manufacturers making up the rest.

$1,053in general payments, 2019–2025

Across 12 payments — averaging $87.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$639
  • Zimmer Biomet$299
  • Smith+Nephew$115
$8in ownership & investment interests, 2019–2025

Across 1 payment — averaging $7.50 each. An ownership or investment interest held by the physician or an immediate family member.

  • Moximed, Inc$8

What the payments were for

  • Travel & lodging$51048%
  • Food & beverage$31630%
  • Education$22722%

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex8$639
Zimmer Biomet3$299
Smith+Nephew1$115

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,053 in reported general payments places this provider in the 55th percentile of 21 hand surgery providers in Nebraska.

See all hand surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$205,027
Medicare patients
601
Services billed
3,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen134$1,056
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen45$389
Celecoxib12$250
Meloxicam55$226
Tramadol Hcl47$132
Gabapentin22$128
Methylprednisolone18$120

Paid to pharmacies, not to this prescriber.

Other hand surgery in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →